Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
Clinical trial NCT01532908 · TERMINATED
Trial details
- NCT number
- NCT01532908
- Sponsor
- MassBiologics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-21
- Primary completion
- 2015-08-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.